Acute immune intravascular hemolysis can also represent a delayed hemolytic transfusion reaction. This is a consideration in this case, because the patient received 2 units of red cells 2 weeks before ...
Low-dose Revlimid delayed transfusion dependency and improved treatment response rates in non-transfusion dependent MDS patients. Revlimid reduced the risk of transfusion dependency by 69.8% compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback